Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases

World Journal of Surgery

Volumn 26, Issue 8, 2002, Pages 991-997

  Hellman, Per ^a   Lundström, Tobias ^a   Öhrvall, Ulf ^b   Eriksson, Barbro ^a   Skogseid, Britt ^a   Öberg, Kjell ^a   Janson, Eva Tiensuu ^a   Åkerström, Göran ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ALPHA INTERFERON; BIOCHEMICAL MARKER; CHROMOGRANIN A; GELFOAM; OCTREOTIDE; SOMATOSTATIN DERIVATIVE; TUMOR MARKER;

ABDOMINAL PAIN; ADULT; AGED; ARTIFICIAL EMBOLISM; CANCER SURGERY; CANCER SURVIVAL; CARCINOID; COLON RESECTION; CONFERENCE PAPER; DIGESTIVE SYSTEM CANCER; FEMALE; HUMAN; INTESTINE OBSTRUCTION; INTESTINE RESECTION; LIVER METASTASIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MESENTERY LYMPH NODE; MIDGUT; PREOPERATIVE PERIOD; PROGNOSIS; SYMPTOMATOLOGY; WEIGHT REDUCTION; ARTICLE; EVALUATION; INTESTINE TUMOR; LIVER TUMOR; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL; TREATMENT OUTCOME; URINE;

CARCINOID TUMOR; FEMALE; HUMANS; HYDROXYINDOLEACETIC ACID; INTESTINAL NEOPLASMS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 0036688512     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-002-6630-z     Document Type: Conference Paper

References (11)

1. Godwin JD. Carcinoid tumors: an analysis of 2837 cases. Cancer 1975;36:560-569
2. Berge T, Linell F. Carcinoid tumours: frequency in a defined population during a 12-year period. Acta Pathol. Microbiol. Scand. [A] 1976;84:322-330
3. Åkerström G, Hellman P, Öhrvall U. Surgical endocrinology. In Doherty G, Skogseid B, editors, Midgut and Hindgut Carcinoid Tumors, Philadelphia, Lippincott, Williams and Wilkins, 2000;447-459
4. Makridis C, Rastad J, Oberg K, et al. Progression of metastases and symptom improvement from laparotomy in midgut carcinoid tumors. World J. Surg. 1996;20:900-907
5. Ohrvall U, Eriksson B, Juhlin C, et al. Method for dissection of mesenteric metastases in mid-gut carcinoid tumors. World J. Surg. 2000;24:1402-1408
6. Wangberg B, Westberg G, Tylen U, et al. Survival of patients with disseminated midgut carcinoid tumors after aggressive tumor reduction. World J. Surg. 1996;20:892-899
7. Janson ET, Holmberg L, Stridsberg M, et al. Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center. Ann. Oncol. 1997;8:685-690
8. Onaitis MW, Kirshbom PM, Hayward TZ, et al. Gastrointestinal carcinoids: characterization by site of origin and hormone production. Ann. Surg. 2000;232:549-556
9. Soreide JA, van Heerden JA, Thompson GB, et al. Gastrointestinal carcinoid tumors: long-term prognosis for surgically treated patients. World J. Surg. 2000;24:1431-1436
10. Ahlman H. The role of surgery in patients with advanced midgut carcinoid tumours. Digestion 1996;57:86-87
11. Nave H, Mossinger E, Feist H, et al. Surgery as primary treatment in patients with liver metastases from carcinoid tumors: a retrospective, unicentric study over 13 years. Surgery 2001;129:170-175